Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 1 min

In memoriam Jules Angst, MD

AI Summary
  • Pioneering contributions to mood disorder research and psychiatric classification, shaping diagnostic understanding and clinical approaches worldwide.
  • Landmark longitudinal clinical studies and advocacy for lithium prophylaxis established treatment evidence and long term management strategies for mood disorders.
  • Enduring influence as IGSLi leader, mentor and role model for generations of clinicians and researchers in psychiatric practice and scholarship.
Summarise with AI (MRCPsych/FRANZCP)

Int J Bipolar Disord. 2026 Aug 3;14(1):29. doi: 10.1186/s40345-026-00433-x.

ABSTRACT

This in memoriam honours Professor Jules Angst, MD, and reflects on his major contributions to mood disorder research, psychiatric classification, longitudinal clinical studies, and lithium prophylaxis. It also commemorates his enduring influence on IGSLi, clinical psychiatry, and generations of researchers and clinicians.

PMID:42545458 | DOI:10.1186/s40345-026-00433-x

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD